Contributed Commentary by David Ludvigson
New prospects for improving the rapid diagnosis of sepsis By David Ludvigson
with Hong Kong-Beijing based World Technology East and RedPharm Biotechnology Companies
Clinical article by David Ludvigson
Newly awarded patent entitled "Nanoelectronic Electrochemical Test Device" strengthens protection for Nanōmix's eLab® System.
The Nanōmix rapid POC tests utilize an innovative platform incorporating highly sensitive, low cost carbon nanostructure biosensors that can be used for a wide range of assays and sample types.
Read more ▶